Related Experiment Video
Updated: Dec 31, 2025
Effects of Allogeneic Platelet-Rich Plasma PRP on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description
Published on: March 19, 2018
[Heart transplantation, indications and results at the University Hospital of Liege]
S Brüls1, V Tchana-Sato1, J P Lavigne1
1Service de Chirurgie Cardiovasculaire et Thoracique, CHU Liège, Belgique.
Insights
Heart transplantation is the best treatment for severe heart failure, with survival rates now exceeding 70%. Donor shortages necessitate strict patient selection criteria for this life-saving procedure.
Area of Science:
- Cardiology
- Transplantation Medicine
- Surgical Outcomes
Background:
- Heart transplantation is the gold standard treatment for end-stage heart failure.
- Significant advancements in the last decade have improved outcomes.
- Graft donor scarcity remains a major limitation.
Purpose of the Study:
- To review the current indications for heart transplantation.
- To present the outcomes of the heart transplantation program at the University Hospital of Liège.
Main Methods:
- Review of patient records.
- Analysis of transplant indications.
- Evaluation of post-transplant survival rates.
Main Results:
- The 5-year survival rate following heart transplantation now exceeds 70%.
- Strict selection criteria are essential due to donor organ limitations.
Conclusions:
- Heart transplantation offers excellent results for end-stage heart failure.
- Optimizing donor organ utilization and recipient selection is critical for program success.
Abstract:
Heart transplantation remains undoubtedly the most effective treatment for end-stage heart failure, whatever its cause. Last decade has witnessed significant improvements in terms of morbidity and mortality following heart transplant. The 5-year survival rate is now beyond 70 %. However, the shortage of potential donors limits its use and requires strict criteria before listing a candidate for heart transplantation. Herein, we present a review of current indications and results of the heart transplantation program at the University hospital of Liège.
